[June 15, 2011]

Research and Markets: The Global Osteoporosis Therapeutics Market is Expected to Reach $5.3 Billion by 2018: Understand the Market with Detailed Forecasts & a Pipeline Analysis

Research and Markets (http://www.researchandmarkets.com/research/2666cc/global_osteoporosi) has announced the addition of the "Global Osteoporosis Therapeutics Market: Market Forecast, Patient Flow,Competitive Landscape, and Pipeline Analysis" report to their offering.

The Global Osteoporosis therapeutics market was valued at $5.5 billion in 2010, and is expected to reach $5.3 billion by 2018, decreasing at a CAGR of 0.4% between 2010 and 2018. Patent expirations for many leading osteoporosis therapies result to their mass genericization.

However, factors such as rising elderly population in all seven top pharmaceutical markets along with increasing osteoporosis diagnosis rate and osteoporosis treated rate will help to stabilize the market. Also, Commercial Insights foresees the rapid uptake of Forteo/Forsteo and Prolia as one of a significant market event that offset the declining osteoporosis therapeutics market.

Find out more in this report, Global osteoporosis therapeutics market: Market Forecasts, Patient Flow, Competitive Landscape, and Pipeline Analysis.

The report scope includes osteoporosis therapeutics market forecast for top seven pharmaceutical markets with patient flow aalysis (including epidemiology forecasts, diagnosis population forecasts, and treated population forecasts), current and future competitive landscape, and pipeline analysis.

Research Scope:

• Geographies Covered: The US, Germany, France, UK, Spain, Italy, and Japan
• Forecast Period: 8 Years (2010 to 2018)

Market Analysis:

• Osteoporosis therapeutics market size and forecast by geography
• Insights in to market events that impact the osteoporosis therapeutics market by geography
• Leading therapies by geography

Competitive Landscape Analysis:

• Market share insights of leading brands in the global osteoporosis therapeutics market
• Future market share analysis of the global osteoporosis therapeutics market
• Profiles of leading brands by annual therapy cost and their market shares

Patient Flow Analysis:

• Patient flow study with diagnosis rate and treated population rate by geography
• Analysis and forecasts of osteoporosis prevalence population by geography
• Analysis and forecasts of osteoporosis diagnosis population by geography
• Analysis and forecasts of osteoporosis treated population by geography

Pipeline Analysis:

• Analysis of osteoporosis pipeline molecules by phase of development
• Detailed clinical profiles of high potential phase 3 molecules

Key Topics Covered:

• Osteoporosis
• Global Osteoporosis Therapeutics Market
• Geographic Landscape Analysis
• Current and Future Competition Analysis
• Osteoporosis Therapeutics Market in the US
• Osteoporosis Therapeutics Market in Europe
• Osteoporosis Therapeutics Market in Germany
• Osteoporosis Therapeutics Market in France
• Osteoporosis Therapeutics Market in Spain
• Osteoporosis Therapeutics Market in France
• Osteoporosis Therapeutics Market IN UK
• Osteoporosis Therapeutics Market in Japan
• Unmet Need
• Osteoporosis Drug Development Pipeline Analysis
• Market Participants

Companies Mentioned Include the Following:

• Abbott Laboratories
• Astellas Pharma
• Astellas Pharma
• AstraZeneca
• Bayer
• Bristol-Myers Squibb
• Cephalon
• Chiesi Farmaceutici SpA
• Chugai Pharmaceutical
• Eisai
• Eli Lilly and Company
• Genzyme
• Gilead Sciences
• GlaxoSmithKline
• Hoffmann-La Roche
• King Pharmaceuticals
• Mitsubishi (News - Alert) Pharma
• Mylan Laboratories
• Novartis
• Novo Nordisk
• Pfizer
• PhytoHealth Corporation
• Procter & Gamble
• Radius Health
• Sanofi-Aventis
• Watson Pharmaceuticals
• Wyeth

For a full list of companies mentioned & a product list please visit our website: http://www.researchandmarkets.com/research/2666cc/global_osteoporosi

[ Back To TMCnet.com's Homepage ]